Avient changed chief executives without a transition period, and the market's first reaction was to cut the shares by about 7%. The company reaffirmed its third-quarter and full-year guidance, reducing the evidence of an immediate operating problem, but it did not explain why Ashish Khandpur stepped down.
The board appointed Mike Frank president and chief executive officer effective October 9. Frank previously led UPL Corporation, a $5 billion agricultural-solutions business, and spent 25 years at Monsanto before serving as chief executive of Nutrien Ag Solutions. Khandpur will remain an adviser through December 31, while lead independent director Richard Fearon becomes non-executive chairman.
The combination of an immediate appointment and limited explanation creates a governance question. Reassurance from the guidance matters, but it is not the same as explaining the board's decision or the timing. Investors will need to judge whether the change reflects a planned shift toward tighter execution or a problem that has not yet appeared in financial results.
Avient's August outlook provides the near-term benchmark. The company guided to adjusted earnings per share of $3.10 to $3.25 for 2026, representing 10% to 15% growth, and expected about $0.80 for the third quarter. It also projected adjusted EBITDA of $575 million to $603 million. Avient reaffirmed that guidance on the morning it announced Frank's appointment.
Frank inherits a specialty-materials business already working to expand margins and commercialize new products. The board emphasized his experience in supply chains, technology commercialization and global operations. That background is relevant, but the move from agricultural chemicals into specialty polymers still requires a learning curve across products, customers and capital priorities.
The company's November 4 results will be the first scheduled test. Meeting the roughly $0.80 adjusted EPS target and preserving the full-year range would support management's claim that the transition has not disrupted current operations. Commentary on customer demand, pricing, raw-material costs and the strategic plan will show whether Frank intends to change priorities.
Investors should resist both extremes in reading the selloff. The unchanged guidance makes an immediate earnings collapse less likely based on the available evidence. The unexplained departure and outsider appointment nonetheless justify a higher execution discount until the board and new CEO provide more detail.
The next report cannot settle Frank's long-term record, but it can answer the most urgent question: whether the abrupt leadership change coincides with any deterioration that was not visible when Avient last updated investors.